轉載自 newyor times
A List of the Best-Selling Drugs in U.S
By THE ASSOCIATED PRESS
Published: September 30, 2004
Filed at 3:44 p.m. ET
The top selling drugs in the United States in 2003, their annual sales,
what it treats and its manufacturer. The 2003 data is the most recent
audited figures available.
藥名 營收 用途 公司
1. Lipitor, $6.8 billion, cholesterol, Pfizer Inc.
2. Zocor, $4.4 billion, cholesterol, Merck & Co.
3. Prevacid, $4.0 billion, heartburn, TAP Pharmaceutical Products Inc.
4. Procrit, $3.3 billion, anemia, Johnson & Johnson
5. Zyprexa, $3.2 billion, mental illness, Eli Lilly & Co.
6. Epogen, $3.1 billion, anemia, Amgen Inc.
7. Nexium, $3.1 billion, heartburn, Merck & Co.
8. Zoloft, $2.9 billion, depression, Pfizer Inc.
9. Celebrex, $2.6 billion, arthritis, Pfizer Inc.
10. Neurontin, $2.4 billion, epilepsy, Pfizer Inc.
11. Advair Diskus, $2.3 billion, asthma, GlaxoSmithKline PLC
12. Plavix, $2.2 billion, blood clots, Bristol-Myers Squibb Co.
13. Norvasc, $2.2 billion, high blood pressure, Pfizer Inc.
14. Effexor XR, $2.1 billion, depression, Wyeth
15. Pravachol, $2.0 billion, cholesterol, Bristol-Myers Squibb Co.
16. Risperdal, $2.0 billion, mental illness, Johnson & Johnson
17. Oxycontin, $1.9 billion, pain, Perdue Pharma
18. Fosamax, $1.8 billion, osteoporosis, Merck & Co.
19. Protonix, $1.8 billion, gastrointestinal reflux disease, Wyeth
20. Vioxx, $1.8 billion, arthritis, Merck & Co.
--
有醫療問題歡迎至 http://bbs.keinmal.idv.tw 討論
--
A List of the Best-Selling Drugs in U.S
By THE ASSOCIATED PRESS
Published: September 30, 2004
Filed at 3:44 p.m. ET
The top selling drugs in the United States in 2003, their annual sales,
what it treats and its manufacturer. The 2003 data is the most recent
audited figures available.
藥名 營收 用途 公司
1. Lipitor, $6.8 billion, cholesterol, Pfizer Inc.
2. Zocor, $4.4 billion, cholesterol, Merck & Co.
3. Prevacid, $4.0 billion, heartburn, TAP Pharmaceutical Products Inc.
4. Procrit, $3.3 billion, anemia, Johnson & Johnson
5. Zyprexa, $3.2 billion, mental illness, Eli Lilly & Co.
6. Epogen, $3.1 billion, anemia, Amgen Inc.
7. Nexium, $3.1 billion, heartburn, Merck & Co.
8. Zoloft, $2.9 billion, depression, Pfizer Inc.
9. Celebrex, $2.6 billion, arthritis, Pfizer Inc.
10. Neurontin, $2.4 billion, epilepsy, Pfizer Inc.
11. Advair Diskus, $2.3 billion, asthma, GlaxoSmithKline PLC
12. Plavix, $2.2 billion, blood clots, Bristol-Myers Squibb Co.
13. Norvasc, $2.2 billion, high blood pressure, Pfizer Inc.
14. Effexor XR, $2.1 billion, depression, Wyeth
15. Pravachol, $2.0 billion, cholesterol, Bristol-Myers Squibb Co.
16. Risperdal, $2.0 billion, mental illness, Johnson & Johnson
17. Oxycontin, $1.9 billion, pain, Perdue Pharma
18. Fosamax, $1.8 billion, osteoporosis, Merck & Co.
19. Protonix, $1.8 billion, gastrointestinal reflux disease, Wyeth
20. Vioxx, $1.8 billion, arthritis, Merck & Co.
--
有醫療問題歡迎至 http://bbs.keinmal.idv.tw 討論
--
All Comments